← European Medicine Shortage Tracker · all medicines

Rivastigmina shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Rivastigmina currently has availability issues reported in 2 European registers: Spain, Italy.

Shortage  ATC — · also listed as: RIVASTIGMINA · data refreshed 21 September 2026

Key facts

As of 21 September 2026, 2 of the 8 tracked registers list current availability issues for Rivastigmina, covering 10 affected product presentations. The longest-running open report was filed in Italy on 2021-10-15 and has now been open for about 59 months. Where agencies state a cause, manufacturing problems lead with 7 of the 9 stated-cause reports, followed by commercial decisions or discontinuation with 1. The furthest expected-resolution date currently on file is 2026-11-12; the earliest is 2026-11-12. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇸 SpainShortage
RIVASTIGMINA STADAFARMA 4,5 MG CAPSULAS DURAS EFG, 56 cápsulas
2026-04-282026-11-12Existen otros medicamentos con el mismo principio activo y misma vía.
Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.
register ↗
🇮🇹 ItalyShortage
EXELON
+ 8 more products
NIMVASTID
NIMVASTID
NIMVASTID
RIVASTIGMINA AUROBINDO
RIVASTIGMINA MYLAN PHARMA
RIVASTIGMINA ZENTIVA
RIVASTIGMINA ZENTIVA
RIVASTIGMINA ZENTIVA
2021-10-15Cessata commercializzazione definitiva
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗

New register reports per month

2024-03: 12024-04: 02024-05: 02024-06: 02024-07: 02024-08: 02024-09: 12024-10: 02024-11: 02024-12: 02025-01: 02025-02: 02025-03: 02025-04: 02025-05: 02025-06: 02025-07: 02025-08: 12025-09: 02025-10: 02025-11: 12025-12: 02026-01: 02026-02: 02026-03: 12026-04: 12026-05: 12024-032026-05

Full report history (10 register entries)

Every individual register entry for Rivastigmina in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITEXELONShortage2027-01-29Cessata commercializzazione definitiva
🇮🇹 ITRIVASTIGMINA AUROBINDOShortage2026-10-08Problemi produttivi
🇮🇹 ITRIVASTIGMINA MYLAN PHARMAShortage2026-05-18Problemi produttivi
🇪🇸 ESRIVASTIGMINA STADAFARMA 4,5 MG CAPSULAS DURAS EFG, 56 cápsulasShortage2026-04-282026-11-12Existen otros medicamentos con el mismo principio activo y m
🇮🇹 ITNIMVASTIDShortage2026-03-03Problemi produttivi
🇮🇹 ITNIMVASTIDShortage2025-11-06Problemi produttivi
🇮🇹 ITRIVASTIGMINA ZENTIVAShortage2025-08-31Elevata richiesta/problemi produttivi
🇮🇹 ITRIVASTIGMINA ZENTIVAShortage2024-09-09Elevata richiesta
🇮🇹 ITNIMVASTIDShortage2024-03-21Problemi produttivi
🇮🇹 ITRIVASTIGMINA ZENTIVAShortage2021-10-15Problemi produttivi: forniture discontinue

Frequently asked

Is Rivastigmina currently in shortage in Europe?

Yes. As of 21 September 2026, availability issues are reported in: Spain, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Rivastigmina shortage expected to end?

Agency prognoses on file range from 2026-11-12 to 2026-11-12. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Rivastigmina?

10 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Rivastigmina availability data come from?

Directly from the official medicines-agency registers that list Rivastigmina: AEMPS CIMA (Spain), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Rivastigmina — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rivastigmina/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Rivastigmina availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rivastigmina/">Rivastigmina shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Rivastigmina: availability status across 2 European registers — European Medicine Shortage Tracker (MobiDoctor), 21 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.